Значения термина acute hf на английском

Intravenous treatments for acute HF were heterogeneously administered, irrespective of guideline recommendations.

Concentrations of sST2 have been found increased and related to worse long-term outcomes in patients with acute HF.

This study investigated the prognostic role of circulating BNP molecular forms on risk prediction for patients with acute HF.

Although ANP is administered intravenously for acute HF, a novel therapeutic strategy is its chronic delivery by subcutaneous injection.

This study was designed to assess the ability of T 3 to predict in-hospital outcomes in patients with acute HF.

Conclusions: GH offers incremental prognostic information over the ADHERE score clinical predictors and NT-proBNP for risk stratification of acute HF patients.

Conclusions: Several conventional and novel ECG parameters that reflect repolarization heterogeneity may differentiate patients with acute HF who ultimately recover LVEF.

Conclusions: PENK levels reflect cardiorenal status in acute HF and are prognostic for worsening renal function and in-hospital mortality as well as mortality during follow-up.

In conclusion, low T 3 predicts worse hospital outcomes in patients with acute HF and can be useful in the risk stratification of these patients.

Conclusions: BNP molecular forms, notably BNP 5-32, showed association with poor prognosis at 6 months and 1 year in patients with acute HF.

From May 2011 to April 2013, a total of 12,440 patients were enrolled, 40.5% with acute HF and 59.5% with chronic HF.